Latest Views & News

I continue to no longer recommend selling your FeverTree shares (although I still haven’t tried its products)

By Chris Bailey | Tuesday 3 May 2022

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

It is good to see UK markets opening again this morning. No doubt a few people are worried about higher Bank of England interest rates this week, but frankly I would worry more if it did not raise interest rates (as that would tell you it feared the likelihood of a recession too). Meantime, elsewhere I note that there is an upcoming change at FeverTree (FEVR)...

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £5.99 per month for all articles, the Bearcast, and our seven year archive.

Filed under:

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was